These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28433327)

  • 1. Replacing antibodies with modified DNA aptamers in vaccine potency assays.
    Trausch JJ; Shank-Retzlaff M; Verch T
    Vaccine; 2017 Oct; 35(41):5495-5502. PubMed ID: 28433327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Characterization of an HPV Type-16 Specific Modified DNA Aptamer for the Improvement of Potency Assays.
    Trausch JJ; Shank-Retzlaff M; Verch T
    Anal Chem; 2017 Mar; 89(6):3554-3561. PubMed ID: 28233502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assays for aptamer-based platforms.
    Citartan M; Gopinath SC; Tominaga J; Tan SC; Tang TH
    Biosens Bioelectron; 2012 Apr; 34(1):1-11. PubMed ID: 22326894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacing antibodies with aptamers in lateral flow immunoassay.
    Chen A; Yang S
    Biosens Bioelectron; 2015 Sep; 71():230-242. PubMed ID: 25912679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamers as affinity reagents in an integrated electrophoretic lab-on-a-chip platform.
    Hecht AH; Sommer GJ; Durland RH; Yang X; Singh AK; Hatch AV
    Anal Chem; 2010 Nov; 82(21):8813-20. PubMed ID: 20945866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
    Mittelberger F; Meyer C; Waetzig GH; Zacharias M; Valentini E; Svergun DI; Berg K; Lorenzen I; Grötzinger J; Rose-John S; Hahn U
    RNA Biol; 2015; 12(9):1043-53. PubMed ID: 26383776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Throughput Discovery of Aptamers for Sandwich Assays.
    Csordas AT; Jørgensen A; Wang J; Gruber E; Gong Q; Bagley ER; Nakamoto MA; Eisenstein M; Soh HT
    Anal Chem; 2016 Nov; 88(22):10842-10847. PubMed ID: 27813404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers as a replacement for antibodies in enzyme-linked immunosorbent assay.
    Toh SY; Citartan M; Gopinath SC; Tang TH
    Biosens Bioelectron; 2015 Feb; 64():392-403. PubMed ID: 25278480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamers: current challenges and future prospects.
    Rozenblum GT; Lopez VG; Vitullo AD; Radrizzani M
    Expert Opin Drug Discov; 2016; 11(2):127-35. PubMed ID: 26630462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA aptamer-based rolling circle amplification product as a novel immunological adjuvant.
    Al-Ogaili AS; Liyanage R; Lay JO; Jiang T; Vuong CN; Agrawal S; Kumar TKS; Berghman LR; Hargis BM; Kwon YM
    Sci Rep; 2020 Dec; 10(1):22282. PubMed ID: 33335251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is less more? Lessons from aptamer selection strategies.
    Szeitner Z; András J; Gyurcsányi RE; Mészáros T
    J Pharm Biomed Anal; 2014 Dec; 101():58-65. PubMed ID: 24877649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characterization and validation of 17β-estradiol binding aptamers.
    Svobodová M; Skouridou V; Botero ML; Jauset-Rubio M; Schubert T; Bashammakh AS; El-Shahawi MS; Alyoubi AO; O'Sullivan CK
    J Steroid Biochem Mol Biol; 2017 Mar; 167():14-22. PubMed ID: 27669644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotinine-conjugated aptamer/anti-cotinine antibody complexes as a novel affinity unit for use in biological assays.
    Park S; Hwang D; Chung J
    Exp Mol Med; 2012 Sep; 44(9):554-61. PubMed ID: 22809871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid aptamers as adjuncts to vaccine development.
    Becker KC; Becker RC
    Curr Opin Mol Ther; 2006 Apr; 8(2):122-9. PubMed ID: 16610764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assays for cytokines using aptamers.
    Guthrie JW; Hamula CL; Zhang H; Le XC
    Methods; 2006 Apr; 38(4):324-30. PubMed ID: 16495077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern affinity reagents: Recombinant antibodies and aptamers.
    Groff K; Brown J; Clippinger AJ
    Biotechnol Adv; 2015 Dec; 33(8):1787-98. PubMed ID: 26482034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor Activity.
    Amero P; Lokesh GLR; Chaudhari RR; Cardenas-Zuniga R; Schubert T; Attia YM; Montalvo-Gonzalez E; Elsayed AM; Ivan C; Wang Z; Cristini V; Franciscis V; Zhang S; Volk DE; Mitra R; Rodriguez-Aguayo C; Sood AK; Lopez-Berestein G
    J Am Chem Soc; 2021 May; 143(20):7655-7670. PubMed ID: 33988982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A signal amplification probe enhances sensitivity of antibodies and aptamers based Immuno-diagnostic assays.
    Nussbaum O; Bar Oz M; Tilayov T; Atiya H; Dagan S
    J Immunol Methods; 2017 Sep; 448():85-90. PubMed ID: 28614699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers.
    Yu Y; Liang C; Lv Q; Li D; Xu X; Liu B; Lu A; Zhang G
    Int J Mol Sci; 2016 Mar; 17(3):358. PubMed ID: 26978355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.